UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Earliest Event Reported: September 27, 2004 GELSTAT CORPORATION (Exact name of registrant as specified in its charter) MINNESOTA 0-21394 41-1713474 (State of other jurisdiction (Commission File No.) (IRS Employer Identification of incorporation) Number) 1650 WEST 82ND STREET, SUITE 1040, BLOOMINGTON, MN 55431 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (952) 881-4105 (Former name, former address and former fiscal year, if changed since last report): ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS Effective September 27, 2004, GelStat appointed K. James Ehlen, M.D. to its Board of Directors. It is anticipated that Dr. Ehlen will serve on the Company's audit committee and compensation committee. ITEM 9.01 EXHIBITS Press Release dated September 27, 2004. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 28,2004 GELSTAT CORPORATION ------------------- By: /s/ Stephen C. Roberts --------------------------------------- Stephen C. Roberts, Chief Executive Officer (Principal executive officer) and Authorized Signatory